Share-Based Payment Arrangements (Tables)

3 Months Ended

Mar. 30, 2024

Amounts Recognized in Financial Statements with Respect to Plans

Amounts recognized in the financial statements with respect to these Plans are as follows (in thousands):

	Thirteen Weeks Ended
	March 30, 2024			April 1, 2023
Total cost of the Plans during the period	$	1,724		$	1,852
Amount of related income tax benefit recognized during the period		(1,152	)		(2,751	)
Net cost of the Plans during the period	$	572		$	(899	)

Schedule of Information on Restricted Stock Units

The following table summarizes information regarding the Company’s outstanding restricted stock unit (“RSU”) awards with either a performance condition or a market condition under the Plans:

	Number of RSUs			Weighted Average Grant Date Fair Value
Outstanding at December 30, 2023		132,722		$	138.93
Granted		102,253		$	138.86
Vested shares		(36,249	)	$	131.10
Forfeited		(2,173	)	$	148.85
Outstanding at March 30, 2024		196,553		$	140.23

Schedule of Information on Non-Vested Restricted Stock and Deferred Stock Units

The following table summarizes information regarding the Company’s outstanding shares of non-vested restricted stock and Deferred Stock Units (defined below) under the Plans:

	Number of Shares and Deferred Stock Units			Weighted Average Grant Date Fair Value
Non-vested at December 30, 2023		46,348		$	158.38
Granted		25,151		$	188.78
Vested		(16,169	)	$	152.07
Forfeited		(295	)	$	169.89
Non-vested at March 30, 2024		55,035		$	174.07